Bank of America’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.5M Buy
66,338
+20,375
+44% +$3.93M ﹤0.01% 2784
2025
Q4
$8.7M Buy
45,963
+3,519
+8% +$651K ﹤0.01% 2960
2025
Q3
$7.03M Sell
42,444
-10,022
-19% -$1.63M ﹤0.01% 3668
2025
Q2
$8.04M Buy
52,466
+7,898
+18% +$1.18M ﹤0.01% 3421
2025
Q1
$7.01M Sell
44,568
-41,940
-48% -$6.81M ﹤0.01% 3477
2024
Q4
$13.6M Buy
86,508
+40,052
+86% +$6.74M ﹤0.01% 2638
2024
Q3
$8.24M Sell
46,456
-3,223
-6% -$572K ﹤0.01% 3253
2024
Q2
$8.37M Sell
49,679
-609
-1% -$99.6K ﹤0.01% 3119
2024
Q1
$8.36M Sell
50,288
-59,873
-54% -$9.91M ﹤0.01% 3155
2023
Q4
$18.2M Buy
110,161
+56,859
+107% +$8.75M ﹤0.01% 2249
2023
Q3
$8.3M Buy
53,302
+5,260
+11% +$840K ﹤0.01% 2905
2023
Q2
$7.5M Buy
48,042
+2,615
+6% +$418K ﹤0.01% 2997
2023
Q1
$7.36M Buy
45,427
+6,202
+16% +$1M ﹤0.01% 3125
2022
Q4
$6.27M Buy
39,225
+4,316
+12% +$684K ﹤0.01% 3177
2022
Q3
$4.92M Sell
34,909
-31,388
-47% -$4.75M ﹤0.01% 3371
2022
Q2
$9.66M Buy
66,297
+6,659
+11% +$992K ﹤0.01% 2736
2022
Q1
$9.67M Sell
59,638
-60,982
-51% -$9.88M ﹤0.01% 2896
2021
Q4
$22.8M Buy
120,620
+88,226
+272% +$17M ﹤0.01% 2094
2021
Q3
$6.55M Buy
32,394
+583
+2% +$122K ﹤0.01% 3296
2021
Q2
$6.42M Sell
31,811
-1,596
-5% -$297K ﹤0.01% 3294
2021
Q1
$5.86M Buy
33,407
+1,752
+6% +$317K ﹤0.01% 3252
2020
Q4
$5.37M Buy
31,655
+779
+3% +$128K ﹤0.01% 3067
2020
Q3
$5M Sell
30,876
-4,074
-12% -$663K ﹤0.01% 2914
2020
Q2
$5.7M Sell
34,950
-30,054
-46% -$4.57M ﹤0.01% 2723
2020
Q1
$8.32M Buy
65,004
+32,957
+103% +$4.44M ﹤0.01% 2215
2019
Q4
$4.47M Sell
32,047
-2,456
-7% -$323K ﹤0.01% 3349
2019
Q3
$4.07M Sell
34,503
-3,096
-8% -$385K ﹤0.01% 3397
2019
Q2
$4.85M Buy
37,599
+8,049
+27% +$992K ﹤0.01% 3269
2019
Q1
$3.8M Buy
29,550
+10,631
+56% +$1.34M ﹤0.01% 3426
2018
Q4
$2.1M Buy
18,919
+5,678
+43% +$686K ﹤0.01% 3807
2018
Q3
$1.8M Sell
13,241
-3,022
-19% -$393K ﹤0.01% 4060
2018
Q2
$1.95M Sell
16,263
-1,490
-8% -$176K ﹤0.01% 3994
2018
Q1
$2.14M Sell
17,753
-3,223
-15% -$404K ﹤0.01% 3830
2017
Q4
$2.61M Buy
20,976
+4,152
+25% +$530K ﹤0.01% 3722
2017
Q3
$2.26M Buy
16,824
+765
+5% +$99.6K ﹤0.01% 3883
2017
Q2
$2.02M Buy
16,059
+1,485
+10% +$179K ﹤0.01% 3875
2017
Q1
$1.74M Sell
14,574
-13,848
-49% -$1.62M ﹤0.01% 3995
2016
Q4
$3.06M Buy
28,422
+22,524
+382% +$2.45M ﹤0.01% 3398
2016
Q3
$680K Sell
5,898
-1,492
-20% -$170K ﹤0.01% 4418
2016
Q2
$756K Sell
7,390
-3,037
-29% -$324K ﹤0.01% 4377
2016
Q1
$1.08M Sell
10,427
-2,146
-17% -$224K ﹤0.01% 4055
2015
Q4
$1.6M Buy
12,573
+1,171
+10% +$143K ﹤0.01% 3999
2015
Q3
$1.3M Sell
11,402
-7,685
-40% -$1.02M ﹤0.01% 4132
2015
Q2
$2.57M Sell
19,087
-10,008
-34% -$1.33M ﹤0.01% 3216
2015
Q1
$3.77M Buy
29,095
+15,561
+115% +$1.96M ﹤0.01% 2709
2014
Q4
$1.56M Sell
13,534
-2,804
-17% -$316K ﹤0.01% 3623
2014
Q3
$1.73M Buy
16,338
+1,719
+12% +$174K ﹤0.01% 3517
2014
Q2
$1.39M Buy
14,619
+4,994
+52% +$448K ﹤0.01% 3703
2014
Q1
$875K Sell
9,625
-693
-7% -$67.4K ﹤0.01% 4038
2013
Q4
$914K Sell
10,318
-4,794
-32% -$401K ﹤0.01% 4151
2013
Q3
$1.25M Buy
15,112
+6,813
+82% +$535K ﹤0.01% 3724
2013
Q2
$568K Buy
+8,299
New +$577K ﹤0.01% 4625

Other funds holding BBH

Bank of America's BBH Position: Q1 2026 in Review

Bank of America increased its VanEck Biotech ETF (BBH) stake by 44% in Q1 2026, buying an estimated $3.93M and bringing the position to 66,338 shares worth $12.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2784.

Bank of America first reported a position in BBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.8M in Q4 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Bank of America held 66,338 shares of VanEck Biotech ETF worth $12.5M as of Q1 2026.
  • Bank of America bought 20,375 VanEck Biotech ETF shares in Q1 2026, an estimated $3.93M.
  • VanEck Biotech ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2784 holding.
  • Bank of America first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 52 quarters since.
  • Bank of America's VanEck Biotech ETF position peaked at $22.8M in Q4 2021.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.